Advertisement

Topics

Dividenden-Garant GlaxoSmithKline: Klasse Nachrichten

02:56 EDT 14 Jun 2018 | FinanzNachrichten

Der britische Pharma-Konzern GlaxoSmithKline sorgt sich zunehmend um die Generika-Konkurrenz, insbesondere beim Kassenschlager Advair. Neben der Novartis-Division Sandoz möchte sich auch Mylan ein ...

Original Article: Dividenden-Garant GlaxoSmithKline: Klasse Nachrichten

NEXT ARTICLE

More From BioPortfolio on "Dividenden-Garant GlaxoSmithKline: Klasse Nachrichten"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...